Trial Profile
Randomized trial of Lipid lowering Therapy for Endothelial Function;Statin Monotherapy Compared with Statin/Ezetimibe or Statin/Eicosapentaenoic Acid Combination Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2020
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Atorvastatin/ezetimibe (Primary) ; Eicosapentaenoic acid (Primary)
- Indications Hyperlipidaemia; Ischaemic heart disorders
- Focus Pharmacodynamics
- Acronyms Rapid Estimate
- 28 Jul 2020 Status changed from suspended to completed.
- 10 Jun 2013 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
- 05 Jun 2012 New trial record